Discussion about this post

User's avatar
I, Bayes's avatar

Two things make my stance more cautious than this article's.

First, a part of MELI's business that rarely gets discussed: float. They hold an enormous amount of money that isn't theirs and put it to work funding growth, much like Buffett did with insurance premiums. But regulators are increasingly aggressive about float, requiring more and more of that cash to sit restricted in government bonds or similar instruments.

Second, an 11% discount rate is still too favorable given the equity risk premium in Latin America. Damodaran estimates total ERP for Argentina at 13.94%. For the US it's 4.46%. Add even two points to the discount rate and a big part of terminal value disappears.

I go into both points and run scenario analysis here: https://theinvestlog.com/p/mercado-libre-reverse-dcf-pricing. Would love your thoughts.

John Kirton's avatar

I read that you've added after the results. MELI is four times the company it was five years ago and the share price is almost exactly the same. Moreover management is highly skilled and strongly aligned, the culture looks in great shape and optionality is being added regularly. Margins and profits have taken a hit in the land grab in the face of strong competition. If that concerns you, you should sell because longer term you see problems, where I see higher margins, fast growing cashflows and further opportunities.

In my view margins will return to previous peaks and the surpass them. When that happens Wall St. will turn and most likely become over optimistic.

Previous share price falls have been followed by mini booms. This time history will rhyme yet again. I'm glad to have added plenty at 1600+ or so.

18 more comments...

No posts

Ready for more?